Cargando…
Real‐world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000–2014, focusing on patients aged >60 years
Treatment for patients > 60 years with classical Hodgkin lymphoma (cHL) is problematic; there is no gold standard, and outcome is poor. Using the Swedish Lymphoma Registry, we analysed all Swedish patients diagnosed with cHL between 2000 and 2014 (N = 2345; median age 42 years; 691 patients were ...
Autores principales: | Wahlin, Björn Engelbrekt, Övergaard, Ninja, Peterson, Stefan, Digkas, Evangelos, Glimelius, Ingrid, Lagerlöf, Ingemar, Johansson, Ann‐Sofie, Palma, Marzia, Hansson, Lotta, Linderoth, Johan, Goldkuhl, Christina, Molin, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175745/ https://www.ncbi.nlm.nih.gov/pubmed/35844675 http://dx.doi.org/10.1002/jha2.202 |
Ejemplares similares
-
Splenic marginal zone lymphoma in Sweden 2000–2020: Increasing rituximab use and better survival in the elderly
por: Junlén, Henna‐Riikka, et al.
Publicado: (2023) -
T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients
por: Övergaard, Ninja, et al.
Publicado: (2022) -
Family history of any cancer for childhood leukemia patients in Sweden
por: Li, Xinjun, et al.
Publicado: (2021) -
Plasma thymus and activation‐regulated chemokine (TARC) as diagnostic marker in pediatric Hodgkin lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2020) -
First‐line treatment of stage IIB to stage IV classical Hodgkin lymphoma in Italy, Israel, and Spain: Patient characteristics, treatment patterns, and clinical outcomes
por: Avigdor, Abraham, et al.
Publicado: (2022)